ASFA 2008 Annual Meeting Presentations
The ASFA 2008 Annual Meeting will be held at the Galveston Island Convention Center, Galveston, TX from April 9 - 12, 2008. Posted below are presentations that will be delivered at the ASFA 2008 Annual Meeting (for which ASFA has the speaker's permission to make available for education and training purposes).
Disclaimer
Reference to these materials will be useful but not comprehensive in developing appropriate standards of care. Their use does not confer any professional qualification or standard. Publication of these materials does not constitute an endorsement by ASFA. ASFA has not reviewed these materials to ensure consistency with acceptable practices. The views expressed in these materials represent the opinion of the authors. ASFA expressly dislclaims any liability arising from any inaccuracy or misstatement. Each facility and/or individual referring to these materials should analyze the information, practices, and procedures outlined therein to determine their acceptability for use in the context of their own obligations and within their own facility's standards and procedures.
Wednesday, April 9, 2008
Graduate Apheresis Medical Education Forum
Introductory Comments and Overview of Graduate Apheresis Medical Education Committee
Chester Andrzejewski, MD, PhD, FCAP, Baystate Medical Center, Springfield, MA
ACGME Outcome Project
Beth H. Shaz, MD, Emory University, Atlanta, GA
Apheresis Medicine Fellowship Program
Jeffrey L. Winters, MD, Mayo Clinic, Rochester, MN
Creating a Resident Training Program for Apheresis
Carol Marshall, MD, University of California, Davis, Sacramento, CA
Committee’s Deliberations
Bruce Sachais, MD, PhD, University of Pennsylvania, Philadelphia, PA
Thursday, April 10, 2008
Opening Symposium: TRALI: Understanding an Emerging Challenge
The Clinical Entity of TRALI
Mark Looney, MD, University of California San Francisco, San Francisco, CA
The Immunobiology of TRALI
Patricia M. Kopko, MD, BloodSource, Sacramento, CA
TRALI in the ICU
Ognjen Gajic, MD, MSc, FCCP, Mayo Clinic, Rochester, MN
TRALI Risk Reduction Strategies: The Challenge to the Blood Center
Anne Eder, MD, PhD, American Red Cross, Washington, DC
Membership Session: How to Become Involved in ASFA
Navigating the ASFA Annual Meeting
Sandra Sabin, RN, BSN, HP(ASCP), Mayo Clinic, Rochester, MN
Francis Morrison, MD Memorial Lecture
Challenges and Opportunities for Therapeutic Apheresis
Jeane Hester, MD
Education Session I: Apheresis Operations
Apheresis Product License and Comparability Protocols
Richard Robinson, MBA, MT(ASCP), American Red Cross Biomedical Headquarters, Washington, DC
Teambuilding 101; Tips from Coach’s Playbook!
Tim M. Weisse, BS, MAM, Blood Systems, Scottsdale, AZ
HIPAA; Identity Theft and Laptop Security
Dale Shakotko, MT(ASCP)BB, GISO, Blood Systems Inc., Scottsdale, AZ
Plenary Abstract Session
1. The Relative Safety of Automated Red Cell Procedures and Allogeneic Whole Blood Collection in Young Donors
Anne Eder, MD, PhD
#2. Donor Demographic and Laboratory Predictors of Allogeneic Peripheral Blood Stem Cell Mobilization in an Ethnically Diverse Population
Sumithira Vasu, MD
#3. Extracorporeal Photoimmune Therapy (Ecp) for Refractory Moderately Active Crohn's Disease (CD): A Multicenter, Open-Label Study
Dennis Parenti, MD
Therapeutic Erythrocytapheresis (TE) versus Phlebotomy (P) in the Treatment of Hereditary Hemochromatosis (HH) Patients
Eva Rombout-Sestrienkova, MD
#5. Predictive Modeling and Process Improvement Techniques Deliver Apheresis Platelet Independence in Regional Blood Center
Debra Anderson, MT(ASCP)
#6. Antiplatelet/Anticoagulant Therapy and Risk of Thrombotic Thrombocytopenic Purpura (TTP): Surveillance, Epidemiology and Risk Factors for TTP (Serf-TTP) Study, 2002-2007
Anaadriana Zakarija, MD
#7. The Effects of Central Venous Catheter Size on the Performance and Cost of Extracorporeal Photopheresis for Graft-Versus-Host Disease
Raj Palepu, MBBS
#8. Assessing the Quality of Practice in Apheresis Medicine
Marisa Marques, MD
Recipient of an ASFA Best Abstract Award
Friday, April 11, 2008
Scientific Symposium: The Immunology of New Therapeutic Approaches in Apheresis
Adaptive T-Cell Therapy
Cassian Yee, MD, Fred Hutchinson Cancer Research Center, Seattle, WA
Dendritic Cells in Health, Disease, Vaccines
David L. Urdal, PhD, Dendreon Corporation, Seattle, WA
Autoimmunity and the Heart: Me
Madeleine W. Cunningham, PhD, University of Oklahoma Health Sciences Center, Oklahama City, OK
Dilated Cardiomyopathy: Current Status of Clinical Trials in Apheresis Therapy
Leslie T. Cooper, MD, Mayo Clinic College of Medicine, Rochester, MN
Education Session II: Donor Center
Preparing for Inspections Panel Discussion (Part 1)
Preparing for Inspections Panel Discussion (Part 2)
Mathew Coleman, MD, National Marrow Donor Program, Minneapolis, MN, Jillian Ferschke, BS, UMass Memorial Medical Center, Worcester, MA, and Theresa Stec, BA, MT(ASCP), Baystate Medical Center, Springfield, MA
Managing Donors with Positive or Reactive Infectious Disease Results
Jillian Ferschke, BS, UMass Memorial Medical Center, Worcester, MA
Managing Multiple Technologies in a Donor Center
Jennie Rasmussen, United Blood Service, Fargo, ND
Education Session III: Therapeutic Cytapheresis
Cellular Apheresis: The History
Patricia Golden, RN, HP(ASCP), Greenwood, MN
Red Blood Cell Exchange Transfusion
Nicholas Bandarenko, MD
Cytoreduction in Therapeutic Apheresis
Vladimir Vidanovic, MD, University of Illinois at Chicago, Chicago, IL
Photopheresis
Marisa B. Marques, MD, University of Alabama at Birmingham Hospital, Birmingham, AL
Education Session IV: Donor Center
Automated Blood and Component Collection
Edwin Burgstaler, MT, HP(ASCP), Mayo Clinic, Rochester, MN
Red Cell and Plasma Loss Tracking for Today’s Apheresis Collection Programs
Sheryl Kempin, RN, BSHA, Blood Systems Inc., Scottsdale, AZ
Math in the Donor Center
Wanda Koetz, RN, HP(ASCP), American Red Cross, Roseville, MN
Computer Systems for Donor Eligibility (Part 1)
Computer Systems for Donor Eligibility (Part 2)
Peggy Barlow and Frances Carson
Education Session VI: Quality Assurance
Risk Management
Dave Krugh, MT(ASCP), SBB, CLS, CLCP(NCA), James Cancer Hospital and Solove Research Institute, Columbus, OH
Lean: When Faster Equals Better
Jeff Schuh, BA, Blood Systems Inc., Scottsdale, AZ
Event Management: Self Assessment System Approach
Theresa Stec, BA, MT(ASCP), Baystate Medical Center, Springfield, MA
Biovigilance in Apheresis Medicine: Introductory Concepts
Chester Andrzejewski, MD, PhD, FCAP, Baystate Medical Center, Springfield, MA
Abstract Session I: Therapeutic Apheresis
#9. Unexpected Decline in Platelet Count with TPE Therapy for TTP is Associated with the Strengthening of Inhibitor to ADAMTS13
Nicholas Bandarenko III, MD
#10. Atypical Hemolytic Uremic Syndrome Associated with Pneumococcal Infection and T-Activation Treated Successfully with Plasmapheresis
Dennis Goldfinger, MD
#11. Post-Operative/Post-Trauma Thrombotic Microangiopathy: A Closer Look
Edwin Taft, MD
#12. Is it Safe to Use a High Whole Blood to Anticoagulant Ratio (AC Ratio) in Plasma Exchange?
Shu Huang, MD
#13. Pattern of Symptomatic Recurrence in Myasthenia Gravis Patients Who Had Therapeutic Plasma Exchanges
Ramakrishna Reddy, MD
#14. Red Blood Cell Exchange Transfusion: An Adjunct Treatment of Hemolytic Babesiosis in Asplenic Patients
Malca Kierson, DO
#15. Alternative Method to Determine Hematocrit from Red Cell Units: A Potential Use in the Apheresis Unit
Sharon Farrell, RN, BSN, HP(ASCP)
#16. Antibody Mediated Cardiac Transplant Rejection: Successful Graft Rescue with Immunotherapy
Jan Hofmann, MD
Abstract Session II: Donor Apheresis
#17. Granulocyte Apheresis Donors: The Impact of Hydroxyethyl Starch on Blood Coagulation
Gabriele Stiegler, MD
#18. Significance of Donor CMV Serological Status In The Outcome of Granulocyte Transfusions in Patients with Hematologic Malignancies Measured By PP65
Fernando Martinez, MD
#19. Donor Acceptance and Plasma Collection Efficiency Improvement with Optimized Apheresis Software
Toby Simon, MD
#20. Donor Saefty and Tolerance in Triple Platelet Dose Collections. Results from 2169 Aphereses of a Hemapheresis Multicenter Trial
Rainer Moog, MD, PhD
#21. Donor Adverse Reactions during Automated Double Red Cell and Plateletpheresis Procedures Compared to Whole Blood Collection
Farzal Anwar, MBBS, FRCPA, SBB(ASCP)
#22. Employing Whole Blood Donor Conversion to Increase Platelet Donations - the Purple Top Tube Project
Yvette Miller, MD
#23. Optimising the Quality of Platelet Concentrates Collected with Amicus Device
Jana List, MD
#24. Successful Management of a Program to Increase Productivity in Automated Platelet Collections
Crystal Farrimond, MPH, MT(ASCP)
Saturday, April 12, 2008
Education Session VII: Therapeutic Apheresis
Overview of Clinical Applications of Therapeutic Apheresis
Beth H. Shaz, MD, Emory University, Atlanta, GA
Therapeutic Apheresis in Neurological Disorders
Robert Weinstein, MD, UMass Memorial Medical Center, Worcester, MA
Apheresis for Hematologic Disorders: TTP, SS, Leukemia
Ravindra Sarode, MD, University of Texas Southwestern Medical Center, Dallas, TX
Apheresis for GVHD and CTCL
Beverly Rhodes, RN, MSN, ANP, MD Anderson, Houston, TX
Education Session VIII: Cellular Therapies
Complications Of and Reactions To Hematopoietic Progenitor Cell Collection
Jeffrey L. Winters, MD, Mayo Clinic, Rochester, MN
Review of the Regulatory Issues that Affect Cellular Therapy Services
Sheryl Tran, Mayo Clinic, Rochester, MN
Collection: Optimizing Use of the Equipment
Edward Burgstaler, MT, HP(ASCP), Mayo Clinic, Rochester, MN
Collection: Opposing Methods for HPC Harvests
Sergio Torloni, MD, Mayo Clinic, Phoenix, AZ
Cell Therapies
April Durett, MSc
Closing Symposium: Atypical Thrombotic Microangiopathies
Atypical Hemolytic Uremia Syndrome
Haewon C Kim, MD, Children's Hospital of Philadelphia, Philadelphia, PA
Emerging Concepts of TTP in HIV Disease
Mark E. Brecher, MD, University of North Carolina Hospital, Chapel Hill, NC
Atypical Presentations of TTP
Ravindra Sarode, MD, University of Texas Southwestern Medical Center, Dallas, TX
The Clinical Spectrum of the TTP and HUS Syndromes: The Oklahoma Registry Experience, 1989-2007
James N. George, MD, University of Oklahoma, Oklahoma City, OK
Abstract Session III: Education and Therapeutics
#25. Evaluating a Comprehensive Training Program to Standardize Treatments and Study Practices for Apheresis and Non-Apheresis Experienced Nurses in a Multi Center, Double Blind, Randomized, Sham Controlled Study
Kathy Wiggins, RN, HP(ASCP)
#26. Addressing Challenges in Resident and Fellow Training in Apheresis Medicine
Beth Shaz, MD
#27. Successful Allograft Salvage with Immunotherapy in Acute Humoral Renal Transplant Rejection
Jan Hofmann, MD
#28. Vascular Access Complications and Management in Extracorporeal Photopheresis
Marla Troughton, MD
#29. Outcomes after Erythrocytapheresis for Children with Acute Chest Syndrome
M Paulina Velasquez, MD
#30. An Initial Single-Centre Experience With Plasma Exchange on the Spectra Optia Cell Separator Machine: 106 Consecutive Optia Procedures Compared To 114 Consecutive Cobe Spectra Procedures on the Same Patient Group
Kenny Douglas, MRCP, MRCPath
#31. Management of Vasculitis-Associated Pulmonary Hemorrhage with Therapeutic Plasma Exchange
Yara Park, MD
#32. Preliminary Experience using the Spectra Optia Apheresis System for Therapeutic Plasma Exchange Procedures
David Roxby, M App Sc
#33. Adamts13 Activity Levels in Patients with Human Immunodeficiency Virus Associated Thrombotic Microangiopathy
Yara Park, MD
Abstract Session IV: Cellular Therapy
#34. Use of Pre-Procedure Laboratory Results in Determination of Blood Volume to be Processed for Donor Lymphocyte Infusion (DLI)
Yasuko Erickson, MD
#35. Effect of Blood Prime Hematocrit on Patient's Hematrocit in Pediatric Therapeutic Apheresis Procedures on Cobe Spectra
Ramakrishna Reddy, MD
#36. Prospective Comparison Analysis of the Gambro Bct 1 Cobe Spectra Auto PBSC Set Vs Gambro BCT 1 Cobe Spectra White Blood Cell Set for Collection of Peripheral Blood Progenitor Cells in Multiple Myeloma
Charles Muck, RN, ADN
#37. Will I Have Enough Cells for a Transplant
Kenny Douglas, MRCP, MRCPath
#38. Use of the Hematopoietic Progenitor Cell (HPC) Parameter In Optimizing Timing of Peripheral Blood Stem Cell Collection
Padmanabhan Anand, MD, PhD
#39. Red Blood Cell Units, Recovered from Bone Marrow Harvests, Qualify for Autologous Blood Transfusion
Gerda Leitner, MD
#41. Monocyteapheresis for Generating Dentric Cell Vaccination Therapy with the Amicus System
Volker Witt, MD
#42. The Impact Of Performance Improvement on Peripheral Hematopoietic Progenitor Cell Preparation. A Single Center Experience.
Malca Kierson, DO
#43. Comparison of Two Methods for Peripheral Blood Stem Cell Collection in Adult Patients Using the Cobe SpectraTM
Linda Hill, RN, HP
#44. Use Of Manual Color Monitoring To Enhance Hematopoietic Progenitor Cell Collection On Fenwal Amicus
Edwin Burgstaler, MT, HP(ASCP)